128 related articles for article (PubMed ID: 1130915)
41. Dopamine and dopa urinary excretion in patients with pheochromocytoma--diagnostic implications.
Januszewicz W; Wocial B; Januszewicz A; Gryglas P; Prejbisz A
Blood Press; 2001; 10(4):212-6. PubMed ID: 11800059
[TBL] [Abstract][Full Text] [Related]
42. Urinary catecholamine excretion by healthy children. I. Daily excretion of dopamine, norepinephrine, epinephrine, and 3-methoxy-4-hydroxymandelic acid.
Voorhess ML
Pediatrics; 1967 Feb; 39(2):252-7. PubMed ID: 6017961
[No Abstract] [Full Text] [Related]
43. Clinical evaluation of catecholamine excretion.
Petrásek J; Dubovský J; Charvát J
Endokrinologie; 1966 Dec; 50(5):308-16. PubMed ID: 5989933
[No Abstract] [Full Text] [Related]
44. Urinary catecholamines and the diagnosis of phaeochromocytoma in Auckland.
McNeil AR; Woollard GA
N Z Med J; 1997 Sep; 110(1051):331-3. PubMed ID: 9323371
[TBL] [Abstract][Full Text] [Related]
45. Renal functional status and patterns of catecholamine excretion.
Itskovitz HD; Wynn NC
J Clin Hypertens; 1985 Sep; 1(3):223-7. PubMed ID: 3835235
[TBL] [Abstract][Full Text] [Related]
46. [Urinary catecholamine excretion and cardiac output in hypertensive patients].
Beloev I; Elenkova A; Pavlov D
Vutr Boles; 1982; 21(2):85-91. PubMed ID: 7101894
[TBL] [Abstract][Full Text] [Related]
47. Decreased peripheral dopaminergic activity in essential hypertension?
Kjeldsen SE; Flaaten B; Eide I; Helgeland A; Leren P; Fønstelien E
Scand J Clin Lab Invest; 1983 Feb; 43(1):15-20. PubMed ID: 6622964
[TBL] [Abstract][Full Text] [Related]
48. [The effect of a psychoemotional load on the cardiovascular system and catecholamines in subjects with different levels of arterial pressure].
Kruchinina NA; Poroshin EE
Fiziol Zh SSSR Im I M Sechenova; 1990 Jan; 76(1):33-40. PubMed ID: 2159911
[TBL] [Abstract][Full Text] [Related]
49. [The excretion of vanilmandelic acid, vanillic acid, homovanillic acid and 5-hydroxyindoleacetic acid by urine in smokers and non-smokers].
Schmid E; Tautz NA; Bauersachs E; Krautheim J
Arzneimittelforschung; 1968 Jul; 18(7):819-21. PubMed ID: 5755826
[No Abstract] [Full Text] [Related]
50. Imipramine-mediated effects on levodopa metabolism in man.
Messiha FS; Morgan JP
Biochem Pharmacol; 1974 May; 23(10):1503-7. PubMed ID: 4847533
[No Abstract] [Full Text] [Related]
51. Circadian variations of urinary dopamine, norepinephrine, epinephrine and sodium in normotensive and hypertensive subjects.
Kawano Y; Kawasaki T; Kawazoe N; Abe I; Uezono K; Ueno M; Fukiyama K; Omae T
Nephron; 1990; 55(3):277-82. PubMed ID: 2370928
[TBL] [Abstract][Full Text] [Related]
52. [Excretion of dopamine, noradrenaline, adrenaline, vanilmandelic acid and 5-hydroxyindoleacetic acid in the urine of volunteers treated with adepren].
Tiutiulkova NI; Gorancheva IuI
Eksp Med Morfol; 1975; 14(4):187-9. PubMed ID: 1222713
[TBL] [Abstract][Full Text] [Related]
53. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
[No Abstract] [Full Text] [Related]
54. [Biological study of 2 cases of Gilles de la Tourette's disease].
Yvonneau M
Rev Neurol (Paris); 1972 Jan; 126(1):65-70. PubMed ID: 4508361
[No Abstract] [Full Text] [Related]
55. [Excretion of dopamine (DA), noradrenaline (NA), adrenaline (A) and 3-methoxy-4-hydroxymandelic acid (KMHM) in the urine of patients with essential hypertension].
Stelmasiak T; Sodolski W; Szewczykowski W; Sikorska W
Pol Arch Med Wewn; 1974 Sep; 52(3):291-8. PubMed ID: 4423765
[No Abstract] [Full Text] [Related]
56. [Some characteristics of the state of the sympatho-adrenal system in various hemodynamic variants of hypertension].
Sumarokov AV; Bol'shakova TD; Lukicheva TI; Eristavi NL; Mikhaĭlov AA
Kardiologiia; 1975 May; 15(5):28-32. PubMed ID: 239270
[TBL] [Abstract][Full Text] [Related]
57. [Changes in the levels of adrenergic and serotoninergic indices in patients with depressive states].
Misionzhnik EIu; Vertogradova OP; Krasnov VN; Salenko BB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):543-51. PubMed ID: 6168150
[TBL] [Abstract][Full Text] [Related]
58. Long-term effects of unilateral 6-hydroxydopamine destruction of the dopaminergic nigrostriatal pathway on the urinary excretion of catecholamines (dopamine, norepinephrine, epinephrine) and their metabolites in the rat.
Peyrin L; Cottet-Emard JM; Javoy F; Agid Y; Herbet A; Glowinski J
Brain Res; 1978 Mar; 143(3):567-72. PubMed ID: 274167
[No Abstract] [Full Text] [Related]
59. Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques.
Pedersen EB; Christensen NJ
Acta Med Scand; 1975 Nov; 198(5):373-7. PubMed ID: 1199813
[TBL] [Abstract][Full Text] [Related]
60. [Effect of electroconvulsive therapy on the urinary excretion of homovanillic and vanillic-amygdalic acids in the mentally ill].
Pacyna M; Pietruszewska I; Krysa G
Psychiatr Pol; 1977; 11(3):303-11. PubMed ID: 897016
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
